Total Receivables - Daewoong Pharma (KRX:069620) - Alpha Spread

Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 138 700 KRW -0.93% Market Closed
Market Cap: 1.6T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Daewoong Pharma
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Daewoong Pharma
Total Receivables Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Daewoong Pharma
KRX:069620
Total Receivables
â‚©178B
CAGR 3-Years
6%
CAGR 5-Years
-3%
CAGR 10-Years
6%
Yuhan Corp
KRX:000100
Total Receivables
â‚©628B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
11%
SK Biopharmaceuticals Co Ltd
KRX:326030
Total Receivables
â‚©115.8B
CAGR 3-Years
109%
CAGR 5-Years
138%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Total Receivables
â‚©188.7B
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Total Receivables
â‚©72.5B
CAGR 3-Years
23%
CAGR 5-Years
12%
CAGR 10-Years
8%
C
Celltrion Pharm Inc
KOSDAQ:068760
Total Receivables
â‚©207B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
17%

See Also

What is Daewoong Pharma's Total Receivables?
Total Receivables
178B KRW

Based on the financial report for Jun 30, 2024, Daewoong Pharma's Total Receivables amounts to 178B KRW.

What is Daewoong Pharma's Total Receivables growth rate?
Total Receivables CAGR 10Y
6%

Over the last year, the Total Receivables growth was -1%. The average annual Total Receivables growth rates for Daewoong Pharma have been 6% over the past three years , -3% over the past five years , and 6% over the past ten years .

Back to Top